BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Biofuel
,
Trichostatin A
,
rs6983267
,
IGF1
,
glucose metabolic process
,
Influenza
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
caspase 1 inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
Caspase-independent necrotic death activated in apoptosis-resistant glioblastoma cells
Chronic lymphocytic leukemia cells CD19+ treated with para-caspase MALT1 inhibitor MI-2
Acute myeloblastic leukemia Kasumi-1 cells expressing RUNX1-RUNX1T1 (AML1-ETO) or RUNX1 siRNA
Breast epithelial cells surviving treatment with TRAIL
Hepatocellular carcinoma HepG2 cells, a model of drug induced liver injury
Explore Curated Studies Results
Literature
Most Relevant Literature
Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome.
CrmA gene transfer rescued CsA-induced renal cell apoptosis in graft kidney.
Cowpox virus serpin CrmA is necessary but not sufficient for the red pock phenotype on chicken chori…
The ectromelia virus SPI-2 protein causes lethal mousepox by preventing NK cell responses.
Chronic graft dysfunction and improvement by cytokine response modifier a protein transfection.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Caspase Inhibition in Islet Transplantation
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosi…
Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH)…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ